InvestorsHub Logo

sentiment_stocks

06/11/21 10:04 AM

#383996 RE: Truthfan #383951

That is again, quite interesting, Truthfan.

Odd, too, that the FDA did not discuss with the Ad Com the issue of the beta-amyloid and its elimination possibly being indicative of a future benefit. I know I appreciate the updates you're giving.

the drug's ability to eliminate beta-amyloid, which it said was "reasonably likely to result in clinical benefit."

CherryTree1

06/11/21 7:07 PM

#384160 RE: Truthfan #383951

I was looking at this earlier today TruthFan.
How do you read this?
Is this good or bad for DCVACX?
Are these 3 people those that would have voted to approve DCVAX or Disapprove?
They voted to disapprove this treatment.
. . . so are the resignations good for DCVAX approval prospects.
I wasn't sure how to read this.
Were the 3 voting purely on the what they viewed as the scientific proven merits of the the treatment and Biogen somehow had some hook in the FDA to over-ride or were the 3 the ones that were being impediments when there was proof the treatment was effective.
It is hard for me to tell which is which in the case.
Thoughts?

LearningEveryTrade

06/12/21 9:55 AM

#384207 RE: Truthfan #383951

FDA BIIB... I heard one report that the new drug helps with the cause, and not symptoms...so, I wonder how Short the advisers and their inner circles were. I mean, follow the money.. they think slam dunk for rejection and the opposite happens. Look at the immediate uproar...why so upset... follow the money.
Same reason no dentist's cure cavities.
IMHO.
Long Live NWBO !!! and cancer patients across the globe....